Elizabeth Forminard - Oct 17, 2022 Form 3 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Executive VP, General Counsel
Signature
Raavi Deol, as attorney-in-fact for Elizabeth Forminard
Stock symbol
JNJ
Transactions as of
Oct 17, 2022
Transactions value $
$0
Form type
3
Date filed
10/26/2022, 04:47 PM
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JNJ Common Stock 3.21K Oct 17, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JNJ Employee Stock Options (Right to Buy) Oct 17, 2022 Common Stock 11.5K $115.67 Direct F1
holding JNJ Employee Stock Options (Right to Buy) Oct 17, 2022 Common Stock 8.92K $129.51 Direct F1
holding JNJ Employee Stock Options (Right to Buy) Oct 17, 2022 Common Stock 9.34K $131.94 Direct F1
holding JNJ Employee Stock Options (Right to Buy) Oct 17, 2022 Common Stock 13.1K $151.41 Direct F1
holding JNJ Employee Stock Options (Right to Buy) Oct 17, 2022 Common Stock 10.8K $164.62 Direct F1
holding JNJ Employee Stock Options (Right to Buy) Oct 17, 2022 Common Stock 8.4K $165.89 Direct F1
holding JNJ Restricted Share Units Oct 17, 2022 Common Stock 979 Direct F2
holding JNJ Restricted Share Units Oct 17, 2022 Common Stock 1.02K Direct F2
holding JNJ Restricted Share Units Oct 17, 2022 Common Stock 851 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vested and exercisable on the third anniversary of the date of the grant.
F2 Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

Remarks:

forminardpoa1.txt